08:15 AM EDT, 09/24/2025 (MT Newswires) -- Predictmedix AI ( PMEDF ) said Wednesday it is developing an adaptive-AI engine to simulate, and predict outcomes across multi-site clinical trials. The SaaS-based platform is intended to provide trial simulation, cross-trial learning, cost/outcome modeling, and full regulatory traceability. According to a statement, the global clinical trials market is projected to reach $123.5...

Sept 24 (Reuters) - Alcon AG: * BROADWOOD - BROADWOOD SAYS STAAR SURGICAL DEAL DELIVERS LESS VALUE THAN ALTERNATIVES (CORRECTS SOURCE TO BROADWOOD NOT STAAR SURGICAL) * BROADWOOD - EXECUTIVES TO EARN $55 MILLION IF DEAL CLOSES (CORRECTS SOURCE TO BROADWOOD NOT STAAR SURGICAL) * BROADWOOD URGES STOCKHOLDERS TO VOTE AGAINST MERGER (CORRECTS SOURCE TO BROADWOOD NOT STAAR SURGICAL) *...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...

08:18 AM EDT, 09/24/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) and Hetero Labs will start selling low-cost generic versions of Lenacapavir, an HIV prevention drug, for about $40 per year, beginning in 2027, Unitaid and the Gates Foundation said Wednesday. Lenacapavir, developed by Gilead Sciences ( GILD ) and approved under the brand name Yeztugo, is a twice-yearly injection...